About UMEDICA :
UMEDICA Laboratories is an industry leader in the development, manufacturing, and export of high-quality pharmaceutical formulations.
With decades of operational excellence and approvals from major global regulatory bodies (USFDA, EU, PIC / S), UMEDICA is expanding its Regulatory Affairs leadership team to support global growth.
We are looking for an experienced Senior Manager - Regulatory Affairs (US Markets) to spearhead regulatory strategy, submissions, and compliance for the US portfolio.
Key Responsibilities :
Regulatory Strategy & Leadership :
- Lead regulatory strategies for the US market across development, filing, and lifecycle stages.
- Drive end-to-end ANDA / NDA submissions, ensuring compliance with USFDA expectations.
- Lead post-approval submissions (PAS, CBE) and annual reporting activities.
- Provide expert regulatory guidance for complex formulations, including injectables and liquid dosage forms.
FDA Interactions :
Lead FDA meeting preparations-Type B / C meetings, briefing packages, and follow-up communications.Handle controlled correspondences, addressing regulatory queries and clarifying development pathways.Cross-functional & External Collaboration :
Partner with R&D, Quality, Manufacturing, and Clinical teams to align regulatory requirements with development goals.Represent Regulatory Affairs in internal meetings and external regulatory interactions.Support commercial launch readiness and lifecycle management activities.Team Leadership :
Lead, mentor, and develop a team of regulatory professionals.Oversee workload planning, performance management, and capability building.Qualifications & Experience :
13-15 years of strong experience in US Regulatory Affairs with proven success in ANDA / NDA filings.Hands-on experience with FDA meetings, controlled correspondence, and complex regulatory negotiations.Strong understanding of US drug development, cGMP regulations, and USFDA submission pathways.Excellent leadership, communication, and stakeholder management skills(ref : iimjobs.com)